OMRON Healthcare Surpasses 50 Million Nebulizers Sold
- Easing Burden of Respiratory Diseases Worldwide since 1978 -
OMRON HEALTHCARE Co., Ltd.
OMRON HEALTHCARE Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, announced that cumulative sales of its nebulizers have surpassed 50 million units. This proud milestone underscores the company’s long-standing commitment to helping people around the world to live healthier lives through management of respiratory conditions.
Image1: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI1fl_gvhJ3KRi.png
Internationally, respiratory diseases are a growing issue, particularly in emerging economies. According to the World Health Organization, some 339 million people suffer from asthma worldwide, with an estimated 3.5 million deaths each year due to Chronic Obstructive Pulmonary Disorder (COPD). Nebulizers, which convert liquid medications into a fine mist that can be inhaled directly into the lungs, are a key tool for easing the burden of respiratory diseases in children and adults alike.
Almost five decades as a trusted partner in respiratory therapy
Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical settings, prioritizing ease of use for families and patients of all ages, from young children to older adults.
Image2: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI2fl_5D7pQUoU.png
Design landmarks ranging from the first ultrasonic models to portable mesh-type and low-noise compressor technologies have made medication delivery more consistent and convenient for millions of users worldwide, including those living with chronic and acute respiratory ailments such as asthma, COPD, RSV bronchitis, cystic fibrosis, and a range of physical disabilities.
Image3: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI3fl_C3N67qeX.png
Comment from Tomohiro Kukita, Senior Manager, Product Planning Strategy HQ of OMRON HEALTHCARE Co., Ltd.: https://kyodonewsprwire.jp/attach/202510308084-O1-S6J3q6El.pdf
About OMRON Healthcare: https://kyodonewsprwire.jp/attach/202510308084-O2-W1MisE02.pdf
For more information, please visit:
Website: https://healthcare.omron.com/
LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
このプレスリリースを配信した企業・団体
- 名称 オムロンヘルスケア株式会社
- 所在地 京都府
- 業種 精密機器
- URL https://www.healthcare.omron.co.jp/
過去に配信したプレスリリース
ネブライザの世界累計販売台数が5,000万台を突破
11/28 17:00
オムロン ヘルスケア、インドのヘルスケアITテック企業「トライコグヘルス社」に追加投資
11/12 15:07
上腕式血圧計と酸素濃縮器が、「2026 German Design Award」を受賞
11/10 14:00
第84回日本公衆衛生学会総会に協賛
10/23 15:00
更年期における症状を8割の女性が放置。受診や対処のきっかけのカギは配偶者やパートナー
10/16 14:00
上腕式血圧計とネブライザ、体温計、酸素濃縮器が2025年度グッドデザイン賞を受賞
10/15 15:00
第47回 日本高血圧学会総会に協賛
10/14 15:00
オムロン ヘルスケア、JSRと「Heartnote®事業」の承継契約を締結
10/11 11:00





